Higher than normal plasma interleukin-6 concentrations in cancer patients with depression

Preliminary findings

Dominique Musselman, A. H. Miller, M. R. Porter, A. Manatunga, F. Gao, S. Penna, B. D. Pearce, J. Landry, S. Glover, J. S. McDaniel, Charles Nemeroff

Research output: Contribution to journalArticle

329 Citations (Scopus)

Abstract

Objective: This study investigated whether cancer patients with and without major depression exhibit immune system abnormalities similar to those reported in medically healthy, depressed subjects without cancer. Method: The study subjects consisted of patients diagnosed with pancreatic, esophageal, or breast cancer. Other groups consisted of subjects with major depression (without cancer) and healthy comparison subjects. Subjects' diagnoses were made with the Structured Clinical Interview for DSM-III-R. Severity of depression was measured with the Hamilton Depression Rating Scale. Plasma concentrations of interleukin-6 (IL-6) and postdexamethasone cortisol were measured. Results: Cancer patients with depression had markedly higher plasma concentrations of IL-6 than healthy comparison subjects and cancer patients without depression. Although significant correlations were found between Hamilton depression scale scores and plasma concentrations of postdexamethasone cortisol, no significant correlations were found between plasma IL-6 and postdexamethasone cortisol concentrations. Conclusions: Higher than normal plasma IL-6 concentrations were associated with a diagnosis of major depression in cancer patients. IL-6 may contribute to sickness behavior that has overlapping symptoms with major depression.

Original languageEnglish
Pages (from-to)1252-1257
Number of pages6
JournalAmerican Journal of Psychiatry
Volume158
Issue number8
DOIs
StatePublished - Aug 16 2001
Externally publishedYes

Fingerprint

Interleukin-6
Depression
Neoplasms
Hydrocortisone
Healthy Volunteers
Illness Behavior
Esophageal Neoplasms
Pancreatic Neoplasms
Diagnostic and Statistical Manual of Mental Disorders
Immune System
Interviews
Breast Neoplasms

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Higher than normal plasma interleukin-6 concentrations in cancer patients with depression : Preliminary findings. / Musselman, Dominique; Miller, A. H.; Porter, M. R.; Manatunga, A.; Gao, F.; Penna, S.; Pearce, B. D.; Landry, J.; Glover, S.; McDaniel, J. S.; Nemeroff, Charles.

In: American Journal of Psychiatry, Vol. 158, No. 8, 16.08.2001, p. 1252-1257.

Research output: Contribution to journalArticle

Musselman, D, Miller, AH, Porter, MR, Manatunga, A, Gao, F, Penna, S, Pearce, BD, Landry, J, Glover, S, McDaniel, JS & Nemeroff, C 2001, 'Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings', American Journal of Psychiatry, vol. 158, no. 8, pp. 1252-1257. https://doi.org/10.1176/appi.ajp.158.8.1252
Musselman, Dominique ; Miller, A. H. ; Porter, M. R. ; Manatunga, A. ; Gao, F. ; Penna, S. ; Pearce, B. D. ; Landry, J. ; Glover, S. ; McDaniel, J. S. ; Nemeroff, Charles. / Higher than normal plasma interleukin-6 concentrations in cancer patients with depression : Preliminary findings. In: American Journal of Psychiatry. 2001 ; Vol. 158, No. 8. pp. 1252-1257.
@article{4d665688cbb34117af1826c981342be6,
title = "Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings",
abstract = "Objective: This study investigated whether cancer patients with and without major depression exhibit immune system abnormalities similar to those reported in medically healthy, depressed subjects without cancer. Method: The study subjects consisted of patients diagnosed with pancreatic, esophageal, or breast cancer. Other groups consisted of subjects with major depression (without cancer) and healthy comparison subjects. Subjects' diagnoses were made with the Structured Clinical Interview for DSM-III-R. Severity of depression was measured with the Hamilton Depression Rating Scale. Plasma concentrations of interleukin-6 (IL-6) and postdexamethasone cortisol were measured. Results: Cancer patients with depression had markedly higher plasma concentrations of IL-6 than healthy comparison subjects and cancer patients without depression. Although significant correlations were found between Hamilton depression scale scores and plasma concentrations of postdexamethasone cortisol, no significant correlations were found between plasma IL-6 and postdexamethasone cortisol concentrations. Conclusions: Higher than normal plasma IL-6 concentrations were associated with a diagnosis of major depression in cancer patients. IL-6 may contribute to sickness behavior that has overlapping symptoms with major depression.",
author = "Dominique Musselman and Miller, {A. H.} and Porter, {M. R.} and A. Manatunga and F. Gao and S. Penna and Pearce, {B. D.} and J. Landry and S. Glover and McDaniel, {J. S.} and Charles Nemeroff",
year = "2001",
month = "8",
day = "16",
doi = "10.1176/appi.ajp.158.8.1252",
language = "English",
volume = "158",
pages = "1252--1257",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "8",

}

TY - JOUR

T1 - Higher than normal plasma interleukin-6 concentrations in cancer patients with depression

T2 - Preliminary findings

AU - Musselman, Dominique

AU - Miller, A. H.

AU - Porter, M. R.

AU - Manatunga, A.

AU - Gao, F.

AU - Penna, S.

AU - Pearce, B. D.

AU - Landry, J.

AU - Glover, S.

AU - McDaniel, J. S.

AU - Nemeroff, Charles

PY - 2001/8/16

Y1 - 2001/8/16

N2 - Objective: This study investigated whether cancer patients with and without major depression exhibit immune system abnormalities similar to those reported in medically healthy, depressed subjects without cancer. Method: The study subjects consisted of patients diagnosed with pancreatic, esophageal, or breast cancer. Other groups consisted of subjects with major depression (without cancer) and healthy comparison subjects. Subjects' diagnoses were made with the Structured Clinical Interview for DSM-III-R. Severity of depression was measured with the Hamilton Depression Rating Scale. Plasma concentrations of interleukin-6 (IL-6) and postdexamethasone cortisol were measured. Results: Cancer patients with depression had markedly higher plasma concentrations of IL-6 than healthy comparison subjects and cancer patients without depression. Although significant correlations were found between Hamilton depression scale scores and plasma concentrations of postdexamethasone cortisol, no significant correlations were found between plasma IL-6 and postdexamethasone cortisol concentrations. Conclusions: Higher than normal plasma IL-6 concentrations were associated with a diagnosis of major depression in cancer patients. IL-6 may contribute to sickness behavior that has overlapping symptoms with major depression.

AB - Objective: This study investigated whether cancer patients with and without major depression exhibit immune system abnormalities similar to those reported in medically healthy, depressed subjects without cancer. Method: The study subjects consisted of patients diagnosed with pancreatic, esophageal, or breast cancer. Other groups consisted of subjects with major depression (without cancer) and healthy comparison subjects. Subjects' diagnoses were made with the Structured Clinical Interview for DSM-III-R. Severity of depression was measured with the Hamilton Depression Rating Scale. Plasma concentrations of interleukin-6 (IL-6) and postdexamethasone cortisol were measured. Results: Cancer patients with depression had markedly higher plasma concentrations of IL-6 than healthy comparison subjects and cancer patients without depression. Although significant correlations were found between Hamilton depression scale scores and plasma concentrations of postdexamethasone cortisol, no significant correlations were found between plasma IL-6 and postdexamethasone cortisol concentrations. Conclusions: Higher than normal plasma IL-6 concentrations were associated with a diagnosis of major depression in cancer patients. IL-6 may contribute to sickness behavior that has overlapping symptoms with major depression.

UR - http://www.scopus.com/inward/record.url?scp=0034893542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034893542&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.158.8.1252

DO - 10.1176/appi.ajp.158.8.1252

M3 - Article

VL - 158

SP - 1252

EP - 1257

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 8

ER -